MAGNESIUM SULFATE

1. PURPOSE

To authorize CCP’s to initiate, monitor, and adjust existing intravenous Magnesium Sulfate infusions

2. POLICY

2.1. CCP’s are permitted to initiate, monitor, and adjust existing Magnesium infusions

3. PRECAUTIONS

3.1. Patients who have rhythm disturbances with hemodynamic instability should be cardioverted prior

to initiation of Magnesium Sulfate infusion.

3.2. Magnesium Sulfate attenuates catecholamine release augmenting its antidysrhythmic properties.
3.3. CCP’s should record FHT’s, if applicable, using a handheld doppler along with vitals per protocol.
3.4. Magnesium Sulfate overdose signs include hypoventilation and hyporeflexia
3.5. If signs of overdose develop, discontinue the infusion and administer 500 mg Calcium Chloride

slow IV push.

4. PROCEDURE

4.1. Infusions shall be maintained at the rate specified by the transferring physician for interfacility

transfers. Any changes in rate or a bolus necessary, and no orders obtained, contact transferring
physician or base hospital for direction.

4.2. Do not use one (1) liter volumes for Magnesium Sulfate infusions.

5. ADMINISTRATION

5.1. Pre-Eclampsia:

5.1.1.  Initial bolus dose is 4 gm in 100 ml LR or NS over 15-30 minutes.
5.1.2.  After initial bolus is completed, initiate an infusion at the rate of 2 gm/hr. To mix add 20

gm to 500 ml LR or NS.

5.2. Torsades de Pointes (Polymorphic V-Tach):

5.2.1.  Dilute 2 grams Magnesium Sulfate in 10 ml LR or NS and administer over 5 mins.

5.3. Severe Asthma/Reactive Airway Disease:

5.3.1.  Administer 50 mg/kg Magnesium Sulfate diluted in 50 ml NS over 20 mins. Maximum dose
is 2 grams. Consult with transferring physician or base hospital if a higher dose is needed.

5.4. Eclampsia Seizures:

5.4.1.  Administer 2 grams Magnesium Sulfate IV/IO/IM/IN. Repeat q 5 mins x 2 to a max of 6 mg.
5.4.2.  Initiate Magnesium Sulfate infusion at 2 gm/hr and contact transferring physician or base

hospital.

20

